Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. The company is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like ant... Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. The company is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. Show more
First gamma delta CAR T cell therapy with the potential to address solid tumors entering clinical trials Preliminary Phase 1 clinical data expected in the first half of 2025 Adicet Bio, Inc...
Enrollment underway for lupus nephritis (LN) patients Preliminary clinical data in LN anticipated in 1H25 Initiation of patient enrollment in systemic lupus erythematosus (SLE), systemic...
-Data demonstrate characteristics essential for treatment of autoimmune diseases, including robust tissue homing and complete CD19+ B cell depletion in secondary lymphoid tissue -Results...
ADI-001 Phase 1 clinical trial expanded to include a total of six autoimmune disease indications; preliminary clinical data in lupus nephritis (LN) anticipated in 1H25 Strong balance sheet with...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.1621 | -14.0956521739 | 1.15 | 1.17 | 0.93 | 880128 | 0.98898561 | CS |
| 4 | -0.4721 | -32.3356164384 | 1.46 | 1.48 | 0.93 | 546162 | 1.15543621 | CS |
| 12 | -0.4721 | -32.3356164384 | 1.46 | 1.63 | 0.93 | 484935 | 1.3418107 | CS |
| 26 | -0.6321 | -39.0185185185 | 1.62 | 1.71 | 0.93 | 663399 | 1.35685058 | CS |
| 52 | -0.2021 | -16.9831932773 | 1.19 | 3.77 | 0.93 | 1010068 | 2.00311633 | CS |
| 156 | -8.3521 | -89.4229122056 | 9.34 | 21.87 | 0.93 | 785111 | 6.80194279 | CS |
| 260 | -13.9921 | -93.4052069426 | 14.98 | 21.87 | 0.93 | 597624 | 7.09953324 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
